Literature DB >> 17098256

The role of comorbid major depressive disorder in the clinical presentation of adult ADHD.

Aline G Fischer1, Claiton H D Bau, Eugenio H Grevet, Carlos A I Salgado, Marcelo M Victor, Katiane L S Kalil, Nyvia O Sousa, Christiane R Garcia, Paulo Belmonte-de-Abreu.   

Abstract

Most adults with attention-deficit/hyperactivity disorder (ADHD) are not recognized and remain untreated, although a large fraction of these individuals are diagnosed and treated for other comorbid mental disorders, such as major depressive disorder (MDD). The fact that MDD is one of the most commonly occurring mental disorders with high comorbidity with adult ADHD raises the question whether such comorbidity is associated with differences in the clinical picture of ADHD. Three hundred and twenty adult ADHD outpatients were evaluated. Diagnoses followed DSM-IV criteria. Interviews to evaluate ADHD and oppositional defiant disorder (ODD) were performed based on the Portuguese version of K-SADS-E. Psychiatric comorbidities were investigated using SCID-IV and MINI. Regression models were applied to test MDD association with clinical and demographic outcomes. Subjects presenting ADHD and MDD had a higher frequency of generalized anxiety disorder and social phobia and a lower frequency of substance dependence, grade repetition and school suspensions, when compared to subjects with ADHD without MDD. Furthermore, adults presenting ADHD and MDD reported higher demand for psychotherapy and pharmacological treatment prior to enrollment in the study when compared to ADHD subjects free of MDD. However, contrary to what could be expected based on these data, the presence of MDD was not associated with an earlier ADHD diagnosis. These results point to the need for research and medical education into an earlier and more efficient ADHD diagnosis in patients who search for mental health care.

Entities:  

Mesh:

Year:  2006        PMID: 17098256     DOI: 10.1016/j.jpsychires.2006.09.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

Review 1.  ADHD documentation for students requesting accommodations at the postsecondary level: Update on standards and diagnostic concerns.

Authors:  Allyson G Harrison; Yontanan Rosenblum
Journal:  Can Fam Physician       Date:  2010-08       Impact factor: 3.275

2.  Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD.

Authors:  Verônica Contini; Marcelo M Victor; Caio C S Cerqueira; Evelise R Polina; Eugênio H Grevet; Carlos A I Salgado; Rafael G Karam; Eduardo S Vitola; Paulo Belmonte-de-Abreu; Claiton H D Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-11-20       Impact factor: 5.270

3.  The role of comorbid depressive symptoms on long-range temporal correlations in resting EEG in adults with ADHD.

Authors:  Matti Gärtner; Maria Strauß; Jue Huang; Eike Ahlers; Holger Bogatsch; Pierre Böhme; Thomas Ethofer; Andreas J Fallgatter; Jürgen Gallinat; Ulrich Hegerl; Isabella Heuser; Knut Hoffmann; Sarah Kittel-Schneider; Andreas Reif; Daniel Schöttle; Stefan Unterecker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-04       Impact factor: 5.270

4.  Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood.

Authors:  Michael C Meinzer; Peter M Lewinsohn; Jeremy W Pettit; John R Seeley; Jeff M Gau; Andrea Chronis-Tuscano; James G Waxmonsky
Journal:  Depress Anxiety       Date:  2013-02-19       Impact factor: 6.505

5.  Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements.

Authors:  Jeanette C Mostert; A Marten H Onnink; Barbara Franke; Martine Hoogman; Marieke Klein; Janneke Dammers; Anais Harneit; Theresa Schulten; Kimm J E van Hulzen; Cornelis C Kan; Dorine Slaats-Willemse; Jan K Buitelaar
Journal:  Eur Neuropsychopharmacol       Date:  2015-08-21       Impact factor: 4.600

6.  Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy.

Authors:  Joseph Gonzalez-Heydrich; Hesham M Hamoda; Laura Luna; Sneha Rao; James McClendon; Peter Rotella; Deborah Waber; Katherine Boyer; Steven V Faraone; Jane Whitney; Danielle Guild; Joseph Biederman
Journal:  Neuropsychiatry (London)       Date:  2012-10-01

7.  Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.

Authors:  Verônica Contini; Marcelo M Victor; Francine Z C Marques; Guilherme P Bertuzzi; Carlos A I Salgado; Katiane L Silva; Nyvia O Sousa; Eugenio H Grevet; Paulo Belmonte-de-Abreu; Claiton H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2010-01-05       Impact factor: 3.575

8.  Serotonin transporter gene polymorphism and the phenotypic heterogeneity of adult ADHD.

Authors:  E H Grevet; F Z C Marques; C A I Salgado; A G Fischer; K L Kalil; M M Victor; C R Garcia; N O Sousa; P Belmonte-de-Abreu; C H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2007-08-10       Impact factor: 3.575

9.  The role of a mineralocorticoid receptor gene functional polymorphism in the symptom dimensions of persistent ADHD.

Authors:  Gustavo Lucena Kortmann; Verônica Contini; Guilherme Pinto Bertuzzi; Nina Roth Mota; Diego Luiz Rovaris; Vanessa Rodrigues Paixão-Côrtes; Leandro Leal de Lima; Eugenio Horacio Grevet; Carlos Alberto Iglesias Salgado; Eduardo Schneider Vitola; Luis Augusto Rohde; Paulo Belmonte-de-Abreu; Claiton Henrique Dotto Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-15       Impact factor: 5.270

10.  Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD.

Authors:  Diane McIntosh; Stan Kutcher; Carin Binder; Anthony Levitt; Angelo Fallu; Michael Rosenbluth
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.